Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 months

Gemma K Reynolds; Emily Klimevski; Natalie R Saunders; Gayani S Teenakoon; Simon J Harrison; Mark Dowling; Mary Ann Anderson; Karin Thursky; Monica A Slavin; Benjamin W Teh

doi:10.1111/bjh.19807

Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 months

Br J Haematol. 2024 Dec;205(6):2498-2502. doi: 10.1111/bjh.19807. Epub 2024 Oct 27.

Authors

Gemma K Reynolds^{1

2

3

4}, Emily Klimevski³, Natalie R Saunders³, Gayani S Teenakoon³, Simon J Harrison^{2

3

5}, Mark Dowling^{2

5}, Mary Ann Anderson^{5

6}, Karin Thursky^{1

2

3}, Monica A Slavin^{1

2

3}, Benjamin W Teh^{1

2

3}

Affiliations

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
³ National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁴ Department of Infectious Diseases and Immunology, Austin Health, Melbourne, Victoria, Australia.
⁵ Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
⁶ Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.

PMID: 39462188
DOI: 10.1111/bjh.19807

No abstract available

Publication types

Letter

Publication types

Grants and funding